18.11.2014 Views

Lisa Kohler, MD - AkronCantonMDNews

Lisa Kohler, MD - AkronCantonMDNews

Lisa Kohler, MD - AkronCantonMDNews

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

Since that time, over 20 studies have been conducted, including<br />

a recent medical analysis that shows a significant improvement<br />

and/or remission of Type 2 diabetes that is quite durable. In<br />

their meta-analysis, Buchwald et al calculated that diabetes improved<br />

or resolved in 86% of bariatric surgery patients, although<br />

diabetic outcomes varied according to operative procedure.<br />

Diabetes resolved completely in 84% of gastric bypass patients.<br />

Biliopancreatic diversion and gastric bypass patients had the most<br />

improvements in hyperlipidemia postoperatively (99% and 97%<br />

resolution, respectively). 9<br />

The improvement appears to be dependent on a number of factors,<br />

including type of procedure. Gastric banding generally results<br />

in a remission rate of approximately 40-50%. For gastric bypass<br />

the resolution rate is approximately 83% and for biliopancreatic<br />

diversion, the resolution rate is 80-100%. A mechanism of resolution<br />

appears to be related to weight loss and perhaps to other<br />

factors. The fact that approximately 30% of patients who have<br />

gastric bypass have an immediate remission (prior to discharge<br />

from the hospital) suggests that factors other than weight loss may<br />

play a very important role.<br />

Recent work by leading investigators suggests that many gut<br />

hormones positively affect insulin resistance and insulin production<br />

including GLP1, GIP, PYY, and Ghrelin. Investigators have<br />

suggested that the bypass of the stomach and duodenum may be<br />

a key factor in altering the secretions of<br />

these hormones.<br />

The durability of this effect has been<br />

shown to be sustained up to and beyond 10<br />

years. A recent study, the Swedish Obesity<br />

Subject Study, compared approximately<br />

2,000 patients who had bariatric procedures<br />

with a matched cohort who did not<br />

have surgery and found the surgical group<br />

had dramatically reduced incidence of<br />

type 2 diabetes and a high remission rate<br />

that was sustained out to 10 years. 10 Other<br />

studies support this durable effect on type<br />

2 diabetes. A 2003 study published in the<br />

Annals of Surgery found that diabetes patients<br />

who received laparoscopic gastric bypass<br />

surgery experienced a mean weight loss of<br />

60%, resulting in resolution of their diabetes<br />

in 83% of cases. 2 The remaining 17% of<br />

patients involved in the study saw marked<br />

improvement in their type 2 diabetes following<br />

surgery. The group most likely to<br />

see complete resolution of their diabetes<br />

included patients who had diabetes for fewer<br />

than five years, were able to control it with<br />

diet alone, and saw the greatest weight loss<br />

after surgery. The study further concluded<br />

that the earlier the surgical intervention,<br />

the more likely it is to have a lasting effect<br />

on type 2 diabetes.<br />

Two recent landmark studies in The New<br />

England Journal of Medicine demonstrate that<br />

bariatric operations reduce long-term mortality<br />

associated with obesity. One study by<br />

Dr. Ted Adams from the University of Utah<br />

compared two cohorts of severely obese<br />

patients, approximately 4,000 patients<br />

each. 11 One group had Roux-en-Y gastric<br />

ILLUSTRATION COURTESY OF CLEVELAND CLINIC<br />

1 2 | | GREATER AKRON/CANTON M.D. NEWS JANUARY-FEBRUARY 2008

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!